Stay updated on LN-145 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the LN-145 in Solid Tumors Clinical Trial page.

Latest updates to the LN-145 in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedAdded Thyroid gland undifferentiated (anaplastic) carcinoma to the Conditions list. This expands the potential tumor types eligible for enrollment across the study.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedRevision tag updated to v3.5.0. No trial details, eligibility criteria, or outcomes were changed.SummaryDifference0.0%

- Check27 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check56 days agoChange DetectedSite-wide revision updated from v3.4.1 to v3.4.2; no changes to study data or patient-facing content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now shows Revision: v3.4.1, with Revision: v3.4.0 no longer displayed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page adds a glossary toggle and updates metadata to Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing the previous lowercase wording Last Update Submitted that met QC Criteria and No FEAR Act data, as well as Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to LN-145 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 in Solid Tumors Clinical Trial page.